MedPage Today on MSN4d
Active Surveillance May Have a Role in Esophageal CancerActive surveillance (AS) following a complete clinical response to neoadjuvant chemoradiotherapy was noninferior to standard ...
Understanding the symptoms, causes, and risk factors of esophageal cancer is important for early detection and prevention.
Ken Kato, MD, PhD, and Harry H. Yoon, MD, MHS, discussed the recent FDA approval of tislelizumab in the first line for ...
Harry H. Yoon, MD, MHS, discusses tislelizumab and platinum-containing chemotherapy in unresectable or metastatic esophageal squamous cell carcinoma whose tumors express PD-L1 at a level of 1 or ...
“FDA approval of TEVIMBRA for the first-line treatment of advanced esophageal squamous cell carcinoma marks a significant step forward in tackling the unmet needs in this challenging disease are ...
The FDA approved Tevimbra with chemotherapy for adults with unresectable or metastatic esophageal squamous cell carcinoma whose tumors express PD-L1. The Food and Drug Administration (FDA) has ...
Esophageal cancer, particularly esophageal squamous cell carcinoma (ESCC), is one of the most prevalent digestive ...
The combination of sintilimab and fruquintinib received conditional approval from China’s National Medical Products Administration (NMPA) for the treatment of patients with advanced endometrial cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback